Johnson & Johnson, COVID Vaccine Trial Participants Drop Out... "Tell Us the Vaccine Risks"
Participant Dropout in Phase 2 Clinical Trial in Spain
Fear Grows Over AstraZeneca Side Effect Reports
![[Image source=Yonhap News]](http://www.asiae.co.kr/news/img_view.htm?img=2020091608361883514_1600212978.jpg)
[Asia Economy Reporter Hyunwoo Lee] It has been reported that some clinical trial participants dropped out during the clinical trials of the COVID-19 vaccine being developed by pharmaceutical company Johnson & Johnson. The participants demanded detailed information about the risks of the vaccine after news broke about side effects from AstraZeneca's COVID-19 vaccine, and some refused to continue and dropped out. As concerns about the vaccine's safety grow, prospects for its release within this year are diminishing.
According to foreign media such as CNBC, on the 15th (local time), La Paz Hospital in Spain announced that some participants dropped out during the clinical trials of the COVID-19 vaccine developed by Johnson & Johnson. The hospital stated that the participants requested detailed information about the risks of the vaccine, but they could not disclose how many participants dropped out. It is known that the participants' fear increased after news emerged about transverse myelitis side effects during AstraZeneca's clinical trials conducted in the UK.
Johnson & Johnson stated that although some participants dropped out in Spain, they have a sufficient pool of participants to continue the clinical trials normally, and if phases 2 and 3 proceed smoothly, the vaccine could be released to the market as early as the beginning of next year.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "Chinese AI Models Cannot Defeat U.S. Big Tech"...Goldman Sachs Forecast
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Previously, Johnson & Johnson announced that its subsidiary Janssen began phase 2 clinical trials of the COVID-19 vaccine on 190 people in Spain starting from the 14th, and results were expected as early as the 22nd of this month. Johnson & Johnson also stated that clinical trials are ongoing in the Netherlands and Germany, with a total of 550 participants across the three countries.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
